Liste des publications

Barjon C, Michaud H-A, Fages A, Dejou C, Zampieri A, They L, Gennetier A, Sanchez F, Gros L, Eliaou J-F, Bonnefoy N* and Lafont V*. (*co-senior authors) IL-21 promotes the development of a CD73-positive Vg9Vd2 T cell regulatory population. Oncoimmunology, 2017, DOI: 10.1080/2162402X.2017.1379642.


Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer KA, Sanders AJ, Jiang WG, Michaud H-A, Colombo PE, Bensussan A, Alberici G, Bastid J, Eliaou J-F and Bonnefoy N. The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. Oncotarget, in press


de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017 Aug 22;14(1):41. doi: 10.1186/s12977 -017-0365-2.


They L, Michaud H-A, Lafont V, Guillot B, Becquart O, Jarlier M, Mollevi C, Eliaou J-F, Bonnefoy N* and Gros L*. (*co-senior authors)PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. Oncoimmunology, 2017, DOI: 10.1080/2162402X.2017 .1353857


Brinza L, Djebali S, Tomkowiak M, Mafille J, Loiseau C, Jouve PE, Bernard S, Buffat L, Lina B, Ottmann M, Rosa-Calatrava M, Schicklin S, Bonnefoy N, Lauvau G, Grau M, Wencker M, Christophe A, Walzer T, LEVERRIER Y, Marvel J. Immune signatures of protective spleen memory CD8 T cells. Scientific Reports, 2016 Nov 6, 37651; doi: 10.1038/srep37651


Limagne E, Euvrard R, Thibaudin M, Boidot R, Végran F, Bonnefoy N, Vincent J, Bengrine L, Ladoire S, Delmas D, Apetoh L, Ghiringhelli F. Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predict the efficacy of a FOLFOX-bevacizumab drug treatment regimen. Cancer Research, 2016 Sep 15;76(18):5241 -52. doi: 10.1158/ 0008-5472.CAN-15-3164.


René C, Lozano C, Villalba M, Eliaou JF. 5' and 3' untranslated regions contribute to the differential expression of specific HLA-A alleles. Eur J Immunol. 2015 Sep 24. doi: 10.1002/eji.201545927.


Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J. IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells. Sci Rep. 2015 Jul 8;5:11874. doi: 10.1038/srep 11874.


Bonnefoy N, Bastid J, Alberici G, Bensussan A, Eliaou JF. CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.
Oncoimmunology. 2015 Feb 3;4(5):e1003015. eCollection 2015 May.


Henri-Alexandre Michaud, Jean-François Eliaou, Virginie Lafont, Nathalie Bonnefoy & Laurent Gros. Tumor antigen-targeting monoclonal antibody-based immunotherapy : Orchestrating combined strategies for the development of long-term antitumor immunity. OncoImmunology Volume 3, Issue 9, 2014


Lafont V, Sanchez F, Laprevotte E, Michaud HA, Gros L, Eliaou JF, Bonnefoy N. Plasticity of γδ T Cells: Impact on the Anti-Tumor Response. Front Immunol. 2014 Dec 8;5:622. doi: 10.3389/fimmu.2014.00622. eCollection 2014.


Bastid J, Regairaz A, Bonnefoy N, Dejou C, Guistiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A, Eliaou JF Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Cancer Immunol Res. 2014 Nov 17.  [Epub ahead of print]


Bastid J, Bonnefoy N, Eliaou JF, Bensussan A. Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis. Oncoimmunology. 2014 Mar 27;3:e28273. eCollection 2014.

Mathieu AL1, Sperandio O, Pottiez V, Balzarin S, Herlédan A, Elkaïm JO, Fogeron ML, Piveteau C, Dassonneville S, Deprez B, Villoutreix BO, Bonnefoy N, Leroux F. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737. J Biomol Screen. 2014 May 8. [Epub ahead of print]


Merindol N, Riquet A, Szablewski V, Eliaou JF, Puisieux A, Bonnefoy N. The emerging role of Twist proteins in hematopoietic cells and hematological malignancies. Blood Cancer J. 2014 Apr 25;4:e206. doi: 10.1038/bcj.2014.22.


Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Curé H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Sci Rep. 2013 Dec 9;3:3456. doi: 10.1038/srep03456.


Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS, Daly SB, Dickerson JE, Mayer J, O'Sullivan J, Juillard L, Urquhart JE, Fawdar S, Marusiak AA, Stephenson N, Waszkowycz B, Beresford MW, Biesecker LG, Black GM, René C, Eliaou JF, Fabien N, Ranchin B, Cochat P, Gaffney PM, Rozenberg F, Lebon P, Malcus C, Crow YJ, Brognard J, Bonnefoy N. Protein kinase C δ deficiency causes mendelian systemic lupus erythematosus with B-cell defective apoptosis and hyperproliferation. Arthritis Rheum. 2013 Aug;65(8):2161-71


Valero JG, Cornut-Thibaut A, Jugé R, Debaud AL, Giménez D, Gillet G, Bonnefoy-Bérard N, Salgado J, Salles G, Aouacheria A, Kucharczak J. µ-Calpain Conversion of Antiapoptotic Bfl-1 (BCL2A1) into a Prodeath Factor Reveals Two Distinct alpha-Helices Inducing Mitochondria-Mediated Apoptosis. PLoS One. 2012;7(6):e38620. Epub 2012 Jun 20.


Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou J-F, Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene, 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2.


Macaire H, Riquet A, Moncollin V, Bie?mont-Trescol M-C, Duc Dodon M, Hermine O, Debaud A-L, Mahieux R, Mesnard J-M, Pierre M, Gazzolo L, Bonnefoy N, Valentin H. Tax-induced expression of the antiapoptotic Bfl-1 protein contributes to survival of HTLV-1- infected T-cells. J Biol Chem. 2012 Jun 15;287(25):21357-70. doi: 10.1074/jbc.M112.340992. Epub 2012 May 2.


Bessoles S., Ni M., Garcia-Jimenez S., Sanchez F., and Lafont V. Role of NKG2D and its ligands in the anti-infectious activity of Vg9Vd2 T cells against intracellular bacteria. Eur. J. Immunol., 2011, 41, 1619-1628.


R. Nasser,M. Pelegrin,H-A. Michaud,M. Plays,M. Piechaczyk and L. Gros. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody. Journal of Virology, 2010, 84:10169-10181.


Brien G, Debaud A-L, Robert X, Oliver L, Trescol-Biemont MC, Cauquil N, Geneste O, Aghajari N, Vallette FM, Haser R, Bonnefoy-Berard N. Carboxy-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1. J Biol Chem., 2009, 284(44):30257-63.


Bessoles S., Dudal S., Besra G.S., Sanchez F., and Lafont V. Human CD4+ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d-dependent but CD4-independent mechanisms. Eur. J. Immunol., 2009, 39, 1-11.


L. Gros, M. Pelegrin, HA. Michaud, S. Bianco, J. Hernandez, C. Jacquet and M. Piechaczyk. Endogenous cytotoxic T-cell response contributes to the long-term anti-retroviral protection induced by a short antibody-based immunotherapy of neonatally infected mice. Journal of Virology, 2008, 82 : 1339- 49.


Brien G, Trescol-Biemont M-C, Bonnefoy-Bérard N. Down-regulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. Oncogene, 2007, 26 (39):5828-5832.


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Conception : ID Alizés